[{"address1": "2101 Cottontail Lane", "city": "Somerset", "state": "NJ", "zip": "08873", "country": "United States", "phone": "732 317 5050", "website": "https://www.legendbiotech.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.", "fullTimeEmployees": 2200, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ying  Huang Ph.D.", "age": 50, "title": "CEO & Director", "yearBorn": 1973, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lori A. Macomber CPA", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Doug  Wallace", "title": "Vice President of Global Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Guowei  Fang Ph.D.", "title": "Chief Scientific Officer & Head of Business Development", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Joanne  Choi", "title": "Senior Manager of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Pepin J.D.", "title": "General Counsel", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Deborah  Wong", "title": "Executive Director of Strategic Marketing & Corporate Communications", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elaine  Qian", "title": "VP & Global Head of Human Resources", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yuhong  Qiu Ph.D.", "title": "Senior Vice President of Global Regulatory Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven J. Gavel", "title": "Senior Vice President of Commercial Development, US & Europe", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 2, "previousClose": 57.39, "open": 57.54, "dayLow": 53.91, "dayHigh": 57.54, "regularMarketPreviousClose": 57.39, "regularMarketOpen": 57.54, "regularMarketDayLow": 53.91, "regularMarketDayHigh": 57.54, "beta": 0.108, "forwardPE": -66.72839, "volume": 784707, "regularMarketVolume": 784707, "averageVolume": 956862, "averageVolume10days": 533370, "averageDailyVolume10Day": 533370, "bid": 53.96, "ask": 54.11, "bidSize": 100, "askSize": 100, "marketCap": 9900392448, "fiftyTwoWeekLow": 38.6, "fiftyTwoWeekHigh": 70.78, "priceToSalesTrailing12Months": 21.711815, "fiftyDayAverage": 54.0364, "twoHundredDayAverage": 54.65795, "currency": "USD", "enterpriseValue": 20071419904, "profitMargins": -0.62504, "floatShares": 161307447, "sharesOutstanding": 183171008, "sharesShort": 10711247, "sharesShortPriorMonth": 11057516, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0585, "heldPercentInsiders": 0.01311, "heldPercentInstitutions": 0.51625, "shortRatio": 10.27, "shortPercentOfFloat": 0.1118, "bookValue": 6.327, "priceToBook": 8.542753, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -285014016, "trailingEps": -1.54, "forwardEps": -0.81, "enterpriseToRevenue": 44.017, "enterpriseToEbitda": -55.38, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "LEGN", "underlyingSymbol": "LEGN", "shortName": "Legend Biotech Corporation", "longName": "Legend Biotech Corporation", "firstTradeDateEpochUtc": 1591363800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ccaf9204-94bb-3c10-bdb1-a5d800652e71", "gmtOffSetMilliseconds": -14400000, "currentPrice": 54.05, "targetHighPrice": 95.0, "targetLowPrice": 60.0, "targetMeanPrice": 82.99, "targetMedianPrice": 86.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 21, "totalCash": 1291838976, "totalCashPerShare": 3.526, "ebitda": -362432992, "totalDebt": 338926016, "quickRatio": 4.734, "currentRatio": 4.841, "totalRevenue": 455991008, "debtToEquity": 29.243, "revenuePerShare": 2.505, "returnOnAssets": -0.12517999, "returnOnEquity": -0.22214001, "freeCashflow": -124139624, "operatingCashflow": -142626000, "revenueGrowth": 1.544, "grossMargins": -0.30759, "ebitdaMargins": -0.79482, "operatingMargins": -0.22501, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]